From: Treatment outcome and compliance to dose-intensified linac-based SBRT for unfavorable prostate tumors using a novel real-time organ-motion tracking
Genitourinary toxicity
Gastrointestinal toxicity
30Â days
90Â days
Grade
1
5 (38.6%)
1 (7.7%)
2 (15.4%)
2
0 (0)
 ≥ 3